502 related articles for article (PubMed ID: 32143721)
1. A double-blind, randomized controlled trial to explore oral tranexamic acid as adjunct for the treatment for postpartum hemorrhage.
Diop A; Abbas D; Ngoc NTN; Martin R; Razafi A; Tuyet HTD; Winikoff B
Reprod Health; 2020 Mar; 17(1):34. PubMed ID: 32143721
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytic drugs for treating primary postpartum haemorrhage.
Shakur H; Beaumont D; Pavord S; Gayet-Ageron A; Ker K; Mousa HA
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012964. PubMed ID: 29462500
[TBL] [Abstract][Full Text] [Related]
3. Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.
Sentilhes L; Daniel V; Darsonval A; Deruelle P; Vardon D; Perrotin F; Le Ray C; Senat MV; Winer N; Maillard F; Deneux-Tharaux C
BMC Pregnancy Childbirth; 2015 Jun; 15():135. PubMed ID: 26071040
[TBL] [Abstract][Full Text] [Related]
4. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis.
Parry Smith WR; Papadopoulou A; Thomas E; Tobias A; Price MJ; Meher S; Alfirevic Z; Weeks AD; Hofmeyr GJ; Gülmezoglu AM; Widmer M; Oladapo OT; Vogel JP; Althabe F; Coomarasamy A; Gallos ID
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012754. PubMed ID: 33232518
[TBL] [Abstract][Full Text] [Related]
5. Effects of tranexamic acid on the amount of bleeding following vaginal delivery and its adverse effects: a double-blind placebo controlled randomized clinical trial.
Kashanian M; Dadkhah F; Tabatabaei N; Sheikhansari N
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5611-5615. PubMed ID: 34024233
[TBL] [Abstract][Full Text] [Related]
6. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
Zuberi NF; Durocher J; Sikander R; Baber N; Blum J; Walraven G
BMC Pregnancy Childbirth; 2008 Aug; 8():40. PubMed ID: 18718007
[TBL] [Abstract][Full Text] [Related]
7. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid for reducing blood loss following vaginal delivery: a double-blind randomized controlled trial.
Igboke FN; Obi VO; Dimejesi BI; Lawani LO
BMC Pregnancy Childbirth; 2022 Mar; 22(1):178. PubMed ID: 35241023
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial.
Ker K; Roberts I; Chaudhri R; Fawole B; Beaumont D; Balogun E; Prowse D; Pepple T; Javaid K; Kayani A; Arulkumaran S; Bates I; Shakur-Still H;
Trials; 2018 Dec; 19(1):712. PubMed ID: 30594227
[TBL] [Abstract][Full Text] [Related]
10. TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial - a study protocol.
Sentilhes L; Daniel V; Deneux-Tharaux C;
BMC Pregnancy Childbirth; 2020 Jan; 20(1):63. PubMed ID: 32005192
[TBL] [Abstract][Full Text] [Related]
11. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
[TBL] [Abstract][Full Text] [Related]
12. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid for treatment of primary postpartum hemorrhage after vaginal delivery: a systematic review and meta-analysis of randomized controlled trials.
Della Corte L; Saccone G; Locci M; Carbone L; Raffone A; Giampaolino P; Ciardulli A; Berghella V; Zullo F
J Matern Fetal Neonatal Med; 2020 Mar; 33(5):869-874. PubMed ID: 30122082
[No Abstract] [Full Text] [Related]
14. Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan.
Abbas DF; Mirzazada S; Durocher J; Pamiri S; Byrne ME; Winikoff B
Reprod Health; 2020 Jun; 17(1):88. PubMed ID: 32503556
[TBL] [Abstract][Full Text] [Related]
15. The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial.
Shady NW; Sallam HF; Elsayed AH; Abdelkader AM; Ali SS; Alanwar A; Abbas AM
J Matern Fetal Neonatal Med; 2019 Jun; 32(11):1806-1812. PubMed ID: 29241383
[TBL] [Abstract][Full Text] [Related]
16. Treatment for primary postpartum haemorrhage.
Mousa HA; Blum J; Abou El Senoun G; Shakur H; Alfirevic Z
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD003249. PubMed ID: 24523225
[TBL] [Abstract][Full Text] [Related]
17. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Williams HM; Price MJ; Merriel A; Gee H; Lissauer D; Moorthy V; Tobias A; Deeks JJ; Widmer M; Tunçalp Ö; Gülmezoglu AM; Hofmeyr GJ; Coomarasamy A
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011689. PubMed ID: 29693726
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Use of Tranexamic Acid for Postpartum Bleeding Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Alam A; Choi S
Transfus Med Rev; 2015 Oct; 29(4):231-41. PubMed ID: 26282735
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic Acid for the Prevention of Blood Loss after Vaginal Delivery.
Sentilhes L; Winer N; Azria E; Sénat MV; Le Ray C; Vardon D; Perrotin F; Desbrière R; Fuchs F; Kayem G; Ducarme G; Doret-Dion M; Huissoud C; Bohec C; Deruelle P; Darsonval A; Chrétien JM; Seco A; Daniel V; Deneux-Tharaux C;
N Engl J Med; 2018 Aug; 379(8):731-742. PubMed ID: 30134136
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
Chaudhuri P; Majumdar A
Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
